Benjamin J. Zeskind is CEO & President at Immuneering Corp (IMRX). They have made 7 open-market trades across 1 company since 2021, most recently 2026-06-23.
CIK 0001870062
7 open-market purchases totalling $255K since 2021, never a sale. Across 7 scored buys the stock is up 37.0% at ninety days, and 33.8 points ahead of the S&P over the same stretch.
7 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| IMRX | 2,315,252 | $8.3M |
Shares reported on the most recent Form 4, priced at the 2026-06-24 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 71% | 29% | 43% |
| Avg Move | +13.0% | +1.8% | +37.0% |
| Alpha | +11.8% | +1.6% | +33.8% |
| Scored | 7 | 7 | 7 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| IMRX | BUY | 2026-06-23 | 2026-06-24 | $4.56 | $11K | +9.4% | -7.2% | -1.1% |
| IMRX | BUY | 2025-07-01 | 2025-07-03 | $3.49 | $35K | +13.1% | -2.0% | +81.7% |
| IMRX | BUY | 2025-06-18 | 2025-06-20 | $2.39 | $50K | +42.5% | +68.3% | +257.5% |
| IMRX | BUY | 2024-03-19 | 2024-03-19 | $2.77 | $55K | -1.4% | -36.6% | -45.0% |
| IMRX | BUY | 2022-03-23 | 2022-03-24 | $8.02 | $24K | -8.2% | -25.0% | -40.1% |
| IMRX | BUY | 2021-09-13 | 2021-09-14 | $22.87 | $48K | +5.4% | -7.9% | -19.8% |
| IMRX | BUY | 2021-08-03 | 2021-08-04 | $15.00 | $31K | +30.0% | +22.9% | +25.8% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.